Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 118 citing articles:

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Harikrishna Makani, Sripal Bangalore, Karen DeSouza, et al.
BMJ (2013) Vol. 346, Iss. jan28 1, pp. f360-f360
Open Access | Times Cited: 229
Targeting NADPH oxidases in vascular pharmacology
Agata Schramm, Paweł T. Matusik, Grzegorz Osmenda, et al.
Vascular Pharmacology (2012) Vol. 56, Iss. 5-6, pp. 216-231
Open Access | Times Cited: 222
DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations
Ahmet Süreyya Rifaioğlu, Esra Nalbat, Volkan Atalay, et al.
Chemical Science (2020) Vol. 11, Iss. 9, pp. 2531-2557
Open Access | Times Cited: 186
Active Vitamin D Treatment for Reduction of Residual Proteinuria
Martin H. de Borst, Reza Hajhosseiny, Hector Tamez, et al.
Journal of the American Society of Nephrology (2013) Vol. 24, Iss. 11, pp. 1863-1871
Open Access | Times Cited: 135
Drug-Induced Hyperkalemia
Chaker Ben Salem, Atef Badreddine, Neila Fathallah, et al.
Drug Safety (2014) Vol. 37, Iss. 9, pp. 677-692
Closed Access | Times Cited: 129
Kinetics and Molecular Docking Studies of the Inhibitions of Angiotensin Converting Enzyme and Renin Activities by Hemp Seed (Cannabis sativa L.) Peptides
Abraham T. Girgih, Rong He, Rotimi E. Aluko
Journal of Agricultural and Food Chemistry (2014) Vol. 62, Iss. 18, pp. 4135-4144
Closed Access | Times Cited: 89
Risk of acute kidney injury associated with the use of fluoroquinolones
Steven T. Bird, Mahyar Etminan, James M. Brophy, et al.
Canadian Medical Association Journal (2013) Vol. 185, Iss. 10, pp. E475-E482
Open Access | Times Cited: 85
Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial
Gema Fernández Juárez, José Luño, V. Barrio, et al.
American Journal of Kidney Diseases (2012) Vol. 61, Iss. 2, pp. 211-218
Closed Access | Times Cited: 81
Blood pressure lowering efficacy of renin inhibitors for primary hypertension
Vijaya M Musini, Kendra AK Lawrence, P Fortin, et al.
Cochrane library (2017) Vol. 2017, Iss. 4
Open Access | Times Cited: 79
Fiend and friend in the renin angiotensin system: An insight on acute kidney injury
Nisha Sharma, Hans‐Joachim Anders, Anil Bhanudas Gaikwad
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 764-774
Open Access | Times Cited: 77
Recomendaciones preventivas cardiovasculares
Á. M. Martín Galán, Carlos Brotons Cuixart, Fernando Villar Álvarez, et al.
Atención Primaria (2012) Vol. 44, pp. 3-15
Open Access | Times Cited: 76
Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues
Claudio Borghi, F. Rossi
High Blood Pressure & Cardiovascular Prevention (2015) Vol. 22, Iss. 4, pp. 429-444
Closed Access | Times Cited: 73
Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD
Rukshana Shroff, Helen Aitkenhead, Nikola Costa, et al.
Journal of the American Society of Nephrology (2015) Vol. 27, Iss. 1, pp. 314-322
Open Access | Times Cited: 67
New Potassium Binders for the Treatment of Hyperkalemia
Bertram Pitt, George L. Bakris
Hypertension (2015) Vol. 66, Iss. 4, pp. 731-738
Closed Access | Times Cited: 66
Renin–Angiotensin System Blocking Drugs
Nicolás Roberto Robles, Isis Cerezo, Román Hernández‐Gallego
Journal of Cardiovascular Pharmacology and Therapeutics (2013) Vol. 19, Iss. 1, pp. 14-33
Closed Access | Times Cited: 70
Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice
Liqing Weng, Wenbin Zhang, Yong Ye, et al.
Acta Pharmacologica Sinica (2014) Vol. 35, Iss. 8, pp. 1005-1014
Open Access | Times Cited: 56
Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
Luz Lozano-Maneiro, Adriana Puente-García
Journal of Clinical Medicine (2015) Vol. 4, Iss. 11, pp. 1908-1937
Open Access | Times Cited: 52
Hemodynamic and Hormonal Changes to Dual Renin–Angiotensin System Inhibition in Experimental Hypertension
Norihito Moniwa, Jasmina Varagić, Sarfaraz Ahmad, et al.
Hypertension (2012) Vol. 61, Iss. 2, pp. 417-424
Open Access | Times Cited: 55
Glycinyl-Histidinyl-Serine (GHS), a Novel Rapeseed Protein-Derived Peptide Has Blood Pressure-Lowering Effect in Spontaneously Hypertensive Rats
Rong He, Sunday A. Malomo, Abraham T. Girgih, et al.
Journal of Agricultural and Food Chemistry (2013) Vol. 61, Iss. 35, pp. 8396-8402
Closed Access | Times Cited: 50
Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment
Dimitris Tousoulis, Θεοδώρα Ψαλτοπούλου, Emmanuel Androulakis, et al.
Cardiovascular Drugs and Therapy (2014) Vol. 29, Iss. 1, pp. 75-88
Closed Access | Times Cited: 49
Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options
Damien Noone, Christoph Licht
Pediatric Nephrology (2013) Vol. 29, Iss. 5, pp. 779-792
Closed Access | Times Cited: 47
Kinetics of the inhibition of renin and angiotensin I-converting enzyme by cod (Gadus morhua) protein hydrolysates and their antihypertensive effects in spontaneously hypertensive rats
Abraham T. Girgih, Ifeanyi D. Nwachukwu, Fida Hasan, et al.
Food & Nutrition Research (2015) Vol. 59, Iss. 1, pp. 29788-29788
Open Access | Times Cited: 44
Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?
Ali Nehme, Kazem Zibara
Hypertension Research (2017) Vol. 40, Iss. 11, pp. 903-909
Closed Access | Times Cited: 42
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
Hiddo J.L. Heerspink, Peggy Gao, Dick de Zeeuw, et al.
European Journal of Preventive Cardiology (2013) Vol. 21, Iss. 3, pp. 299-309
Open Access | Times Cited: 42
Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials
Selçuk Şen, Soner Sabırlı, Tolga Özyiğit, et al.
Therapeutic Advances in Chronic Disease (2013) Vol. 4, Iss. 5, pp. 232-241
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top